Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Brian K. Halak currently holds 327 shares of Evoke Pharma Inc (EVOK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Brian K. Halak has been a net buyer of EVOK stock. They have purchased $101.7M and sold $20.1M worth of shares.
Brian K. Halak's most recent insider trade was on Sep 17, 2021, when they sold 215 shares at $0.00 per share.
Brian K. Halak serves as Executive at Evoke Pharma Inc (EVOK). They have executed 134 insider transactions totaling $121.8M over their tenure at the company.
Brian K. Halak holds the position of Executive at Evoke Pharma Inc, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 19 years and currently hold a stake valued at $0.
Brian K. Halak has shown a buying trading pattern, with $101.7M in total purchases and $20.1M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Brian K. Halak was on Mar 19, 2014, when they sold $41.6M worth of CADX shares. This transaction involved 2,972,678 shares at $14.00 per share.
Brian K. Halak currently owns 327 shares of Evoke Pharma Inc (EVOK), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Brian K. Halak's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Brian K. Halak has 134 Form 4 filings on record as an insider at Evoke Pharma Inc.
Set alerts for Brian K. Halak and 40,000+ other insiders.